Discover the Doptelet Copay
Assistance Program

Eligible commercially insured patients may qualify for the Doptelet Copay Assistance Program

What's the program?

Eligible patients may pay as little as $0 for each Doptelet prescription
Annual maximum benefit up to $15,000

Eligible patients must:

Have commercial insurance that covers Doptelet
Not be enrolled in any state or federal healthcare program such as Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD), or TRICARE
Be 18 years of age or older
Be a resident in the United States or a US Territory

How to enroll:

Approved pharmacies, healthcare professionals, and Doptelet Connect can enroll patients
Patients can enroll themselves as well as their caregivers
Please call 1-833-368-2663 Monday–Friday 8am–8pm ET for more information

Terms and Conditions

Patients pay as little as $0 per prescription. Copay Assistance Program has an annual calendar cap of $15,000
The Copay Assistance Program is void where prohibited by law, taxes, or restricted
This offer is non-transferable, no substitutions are permissible, and this offer cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
Sobi, Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice
The Copay Assistance Program for Doptelet is not insurance and is not intended to substitute for insurance
Patients, pharmacists, and healthcare providers must not seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this Copay Assistance Program. Patients must not seek reimbursement from any health savings, flexible spending, or other healthcare reimbursement accounts for the amount of assistance received from the Copay Assistance Program
Certain information pertaining to your use of the Copay Assistance Program will be shared with Sobi, Inc., the sponsor of the Copay Assistance Program. The information disclosed will include the date the prescription is filled, the number of pills or product dispensed by the pharmacists, and the amount of your copay that will be paid for by using this Copay Assistance Program. For more information, please see the Sobi Privacy Policy at https://sobi-northamerica.com/privacy-policy
Acceptance in this Copay Assistance Program is not conditioned on any past, present, or future purchase, including additional doses
Enrollment for the Copay Assistance Program is valid through the calendar year
Sobi reserves the right to change program terms at any time

OOF! LOOKED ALL OVER AND COULDN'T FIND YOU THAT PAGE.

Get tips and tools sent straight to your inbox.

Join us

404 OOF! LOOKED ALL OVER AND COULDN'T FIND YOU THAT PAGE.

IMPORTANT SAFETY
INFORMATION FOR DOPTELET

What is DOPTELET^® (avatrombopag)?

DOPTELET is a prescription medicine used to treat low blood platelet counts in adults with:

long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure.
chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.

DOPTELET is not used to make platelet counts normal in adults with chronic liver disease or chronic immune thrombocytopenia.

It is not known if DOPTELET is safe and effective in children.

Before you take DOPTELET, tell your healthcare provider about all of your medical conditions, including if you:

have ever had a blood clot.
are pregnant or plan to become pregnant. DOPTELET may harm your unborn baby. Tell your healthcare provider if you become pregnant or think you may be pregnant during treatment with DOPTELET.
are breastfeeding or plan to breastfeed. It is not known if DOPTELET passes into your breast milk. Do not breastfeed during your treatment with DOPTELET and for at least 2 weeks after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. DOPTELET may affect the way other medicines work, and other medicines may affect the way DOPTELET works.

How should I take DOPTELET?

Take DOPTELET exactly as your healthcare provider tells you to take it.
Your healthcare provider will tell you how much DOPTELET to take and when to start taking it.
Your healthcare provider may change your dose of DOPTELET depending on your blood platelet counts.
Take DOPTELET with food.
If you take DOPTELET to treat your low blood platelet counts due to chronic liver disease before a medical or dental procedure, your healthcare provider will check your platelet count before treatment and on the day of your scheduled procedure.
If you take DOPTELET to treat your low blood platelet counts due to chronic immune thrombocytopenia, your healthcare provider will check your platelet count before, during and for at least 4 weeks after stopping your treatment with DOPTELET.
If you are taking DOPTELET prior to a scheduled medical procedure and you miss a dose, contact your healthcare provider for further dosing instructions.
If you are taking DOPTELET for chronic immune thrombocytopenia and you miss a dose of DOPTELET, take it as soon as you remember. Do not take 2 doses at one time to make up for a missed dose. Take your next dose at your usual scheduled time.
If you take too much DOPTELET, call your healthcare provider or go to the nearest hospital emergency room right away.

What are the possible side effects of DOPTELET?

DOPTELET may cause serious side effects, including blood clots. People with chronic liver disease or chronic immune thrombocytopenia and people with certain blood clotting conditions may have an increased risk of developing blood clots. Tell your healthcare provider right away if you have signs and symptoms of a blood clot, including:

swelling, pain, or tenderness in your legs
shortness of breath
chest pain

fast heartbeat
stomach (abdominal) pain or tenderness

The most common side effects of DOPTELET in people with chronic liver disease are:

fever
stomach (abdominal) pain
nausea

headache
tiredness
swelling of the hands or feet

The most common side effects of DOPTELET when used to treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) are:

headache
tiredness
bruising
nosebleed
upper respiratory tract infection

joint pain
bleeding gums
purple or red spots on your skin
runny nose

These are not all the possible side effects of DOPTELET.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store DOPTELET?

Store DOPTELET at room temperature between 68°F to 77°F (20°C to 25°C).
Store DOPTELET tablets in the original package.

Keep DOPTELET and all medicines out of the reach of children.

General information about the safe and effective use of DOPTELET.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use DOPTELET for a condition for which it was not prescribed. Do not give DOPTELET to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about DOPTELET that is written for health professionals.

What are the ingredients in DOPTELET?

Active ingredient: avatrombopag

Inactive ingredients: lactose monohydrate, colloidal silicon dioxide, crospovidone, magnesium stearate and microcrystalline cellulose. Tablet coating film: polyvinyl alcohol, talc, polyethylene glycol, titanium dioxide and ferric oxide yellow.

Please see full Prescribing Information, including the Patient Information Leaflet.

This Patient Information has been approved by the U.S. Food and Drug Administration.

INDICATION & IMPORTANT SAFETY INFORMATION

What is DOPTELET^® (avatrombopag)?

DOPTELET is a prescription medicine used to treat low blood platelet counts in adults with:

long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure.
chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.